5 August 2025
Drug discovery is expensive and time consuming. Machine learning can drastically reduce time and cost and allow collaboration and innovation.
Tag: Hepatitis C
29 July 2025
Malaysia has taken a comprehensive approach, including providing free treatment in public health care facilities and integrating screening into primary health care.
16 November 2021
MOH says sofosbuvir will be given to medical tourists at private hospitals after procuring the drug under a voluntary licence; WTO rules only allow compulsory licensing for public non-commercial use.
7 August 2020
Remdesivir is not in the Malaysian treatment protocol for Covid-19, says Dr Adham Baba.
28 July 2020
Destigmatisation is an important part of the public health effort in eliminating hepatitis as fear of discrimination and stigma can prevent people from getting tested and treated.
17 July 2020
MOH said last November that 4,500 Malaysians were treated with generics of sofosbuvir.
4 December 2019
Gilead announced in August 2017 the expansion of its sofosbuvir voluntary licensing programme to Malaysia.
26 November 2019
The Drugs for Neglected Diseases initiative (DNDi) plans to register ravidasvir in Malaysia next year.
13 November 2019
Only over 50,000 high-risk people were screened this year, out of an estimated 500,000 Malaysians living with Hepatitis C.
30 September 2019
Dr Shuping Wang was instrumental in uncovering two blood donation scandals in the 90s.